Atlas Trials

Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult Participants

Clinical trial NCT06106074 · COMPLETED

Trial details

NCT number
NCT06106074
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2020-08-10
Primary completion
2022-05-23
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.